Compare Kimberly Clark Corp (KMB) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kimberly Clark Corp vs Marsh & McLennan Companies, Inc. — how do they compare? Kimberly Clark Corp trades at $108.5 (market cap $36.01B), while Marsh & McLennan Companies, Inc. trades at $180.04 (market cap $87.77B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 2.4× Kimberly Clark Corp's market cap, and Kimberly Clark Corp pays the higher dividend (4.72%). Which is the better fit depends on your goals.
| KMB | MRSH | |
|---|---|---|
Market Cap | $36.01B | $87.77B |
Sector | Consumer Staples | Financials |
52-Week High | $136.77 | $211.21 |
52-Week Low | $93.05 | $157.32 |
Enterprise Value | $42.55B | $108.61B |
Dividend Yield | 4.72% | 2.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kimberly-Clark (KMB) trades at $108.05, down 0.28% on the day, with a neutral technical signal. The stock shows strong profitability with a net income margin of 12.8% and has beaten earnings estimates for the last three quarters. Recent news highlights its status as a Dividend King and strategic moves like the Arbex joint venture. Cash flow trends indicate operational strength despite recent net outflows.
KMB offers a stable investment with a solid dividend yield and consistent earnings beats, but faces risks from high payout ratios and competitive pressures. Analyst consensus is mixed with a hold-heavy rating, though the $115.33 price target suggests modest upside. Revenue declines in 2025 warrant monitoring for sustained growth.
Marsh (MRSH) trades at $181.59, down 0.32% on the day, with a bullish technical signal from moving averages and support at $180. The company reported strong Q2 2026 earnings, beating estimates with $2.96 EPS versus $2.88 expected, driven by 6% revenue growth to $7.4 billion. Fundamentals show robust profitability with a 14.26% net margin and 27.42% ROE, while valuation ratios like P/E of 22.77 and P/S of 3.26 reflect premium pricing. Recent news highlights a 10% dividend increase to $0.99 per share, payable in August 2026.
The outlook for MRSH is positive, supported by consistent earnings beats and strategic AI investments, but risks include rising operating expenses and softer insurance pricing. Analysts maintain a consensus price target of $203.75, implying 12% upside, with 11 buy ratings outweighing 1 sell. Investors should monitor expense management and organic growth sustainability amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
